Pomegranate Latest Weapon to Fight MRSA
Scientists have discovered that pomegranate rinds combined with two natural products can be turned into an ointment for treating MRSA (Methicillin-Resistant Staphylococcus aureus) and other common hospital infections.
KINGSTON, United Kingdom—Scientists have discovered that pomegranate rinds combined with two natural products can be turned into an ointment for treating MRSA (Methicillin-Resistant Staphylococcus aureus) and other common hospital infections.
Researchers from the University of Kingston’s School of Life Sciences discovered that the infection-fighting properties of pomegranate were greatly enhanced by combining the rind of the fruit with metal salts and vitamin C. Pomegranate rind combined with metal salts was the most effective combination for treating MRSA, while other common hospital infections were better dealt with by all three components—pomegranate rind, metal salts and vitamin C.
"We have developed a topical ointment that can successfully attack a range of drug resistant microbes. It's a significant breakthrough and a striking example of the effectiveness of adding more components to create a more active product," Professor Declan Naughton said. "It shows that nature still has a few tricks up its sleeve. The idea of using a foodstuff is unusual and means that the body should be able to cope more easily with its application; patients are less likely to experience any major side-effects."
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
